Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

MedPlus Health Services Limited July 24, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received three suspension orders for a Drug License of a store situated in the state of mentioned below: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Authority Nature and details of the Date of receipt of Details of the Impact on financial action(s) taken, initiated or direction or order, violation(s)/ operation or other order(s) passed including any contravention(s) activities of the interim or interim committed or alleged listed entity, orders, or any other to be committed quantifiable in communication monetary terms to from the authority the extent possible Assistant Director, Drugs Suspension of Drug License Potential Revenue Control Administration, for two days of store situated Loss of Rs 0.24 lacs. Gulbarga Circle, Gulbarga, at Msk Mill Gulbarga, Karnataka. Karnataka. Assistant Director, Drugs Suspension of Drug License Potential Revenue Order received on Under Rule 65 of Drugs Control Administration, for two days of store situated Loss of Rs 1.11 lacs. 23.07.2026 and Cosmetics Act, Bangalore Circle, Bangalore at Ram Anjaneya Road 1940 and Drugs and Karnataka. Hanumanth Nagar, Karnataka. Cosmetics Rules, 1945 Assistant Director, Drugs Suspension of Drug License Potential Revenue Control Administration, for two days of store situated Loss of Rs 1.05 lacs. Bangalore South Circle, Channapatna Ramanagar Ramanagar, Karnataka Karnataka. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com